TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biotrans i Nord AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
7,543
|
7,002
|
10,003 |
| Financial expenses |
256
|
195
|
102 |
| Earnings before taxes |
-646
|
-1,365
|
-360 |
| EBITDA |
888
|
-85
|
744 |
| Total assets |
9,683
|
12,315
|
8,960 |
| Current assets |
1,985
|
3,032
|
1,503 |
| Current liabilities |
2,302
|
3,416
|
3,091 |
| Equity capital |
406
|
437
|
492 |
| - share capital |
325
|
336
|
334 |
| Employees (average) |
8
|
8
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
4.2%
|
3.5%
|
5.5% |
| Turnover per employee |
943
|
875
|
1,250 |
| Profit as a percentage of turnover |
-8.6%
|
-19.5%
|
-3.6% |
| Return on assets (ROA) |
-4.0%
|
-9.5%
|
-2.9% |
| Current ratio |
86.2%
|
88.8%
|
48.6% |
| Return on equity (ROE) |
-159.1%
|
-312.4%
|
-73.2% |
| Change turnover |
773
|
-3,053
|
-237 |
| Change turnover % |
11%
|
-30%
|
-2% |
| Chg. No. of employees |
0
|
0
|
-2 |
| Chg. No. of employees % |
0%
|
0%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.